Atrás
Rango del Día
$16.12
$17.20
Rango de 52 Semanas
$15.08
$38.99
Volumen
1,732,945
Promedio 50D / 200D
$25.26
/
$26.99
Cierre Anterior
$16.55
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -1.0 | 0.3 |
| P/B | 0.6 | 2.9 |
| ROE % | -46.2 | 3.7 |
| Net Margin % | -41.5 | 3.8 |
| Rev Growth 5Y % | 12.6 | 10.0 |
| D/E | 1.5 | 0.2 |
Precio Objetivo de Analistas
Hold
$30.00
+85.5%
P/E Futuro
7.7
EPS Futuro
$2.15
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
2.8 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$3.10
$3.07 – $3.12
|
3.1 B | 1 |
| FY2029 |
$3.78
$3.74 – $3.80
|
3.1 B | 1 |
| FY2028 |
$3.47
$3.44 – $3.49
|
3 B | 1 |
Puntos Clave
Revenue grew 12.60% annually over 5 years — strong growth
Negative free cash flow of -83.00M
PEG of 0.04 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 14.49%
Capital efficient — spends only 6.89% of revenue on capex
Crecimiento
Revenue Growth (5Y)
12.60%
Revenue (1Y)-1.89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-46.15%
ROIC-14.59%
Net Margin-41.45%
Op. Margin-33.67%
Seguridad
Debt / Equity
1.46
Current Ratio1.50
Interest Coverage-5.18
Valoración
P/E Ratio
-0.97
P/B Ratio0.57
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.89% | Revenue Growth (3Y) | -4.57% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12.60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.73B | Net Income (TTM) | -1.13B |
| ROE | -46.15% | ROA | -19.62% |
| Gross Margin | 46.67% | Operating Margin | -33.67% |
| Net Margin | -41.45% | Free Cash Flow (TTM) | -83.00M |
| ROIC | -14.59% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.46 | Current Ratio | 1.50 |
| Interest Coverage | -5.18 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -0.97 | P/B Ratio | 0.57 |
| P/S Ratio | 0.40 | PEG Ratio | 0.04 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.10B | Enterprise Value | 3.74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.73B | 2.78B | 3.00B | 3.27B | 1.70B |
| Net Income | -1.13B | -2.05B | -10.10M | 548.70M | 704.20M |
| EPS (Diluted) | -16.69 | -30.54 | -0.15 | 9.56 | 16.43 |
| Gross Profit | 1.27B | 1.29B | 1.50B | 1.94B | 1.28B |
| Operating Income | -919.20M | -1.96B | 139.10M | 843.70M | 906.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.77B | 6.42B | 8.56B | 8.86B | 2.43B |
| Total Liabilities | 3.85B | 3.44B | 3.56B | 3.92B | 501.00M |
| Shareholders' Equity | 1.92B | 2.98B | 5.01B | 4.93B | 1.93B |
| Total Debt | 2.80B | 2.68B | 2.61B | 2.85B | 139.30M |
| Cash & Equivalents | 169.80M | 98.30M | 118.90M | 292.90M | 802.80M |
| Current Assets | 1.45B | 1.22B | 1.31B | 1.58B | 1.44B |
| Current Liabilities | 966.10M | 998.80M | 833.80M | 1.01B | 323.50M |